Marc Tessier-Lavigne, Director at REGENERON PHARMACEUTICALS INC (REGN), sold 3,200 shares at $352.20 ($1.1M) on 2014-08-27, disclosed to the SEC on 2014-08-27.
Open-market sale of $1.1M REGN by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $351.62 | 200 | $70K | 6.2% |
| 2 | $352.20 | 3,000 | $1.1M | 93.8% |
| Total | $352.16 avg | 3,200 | $1.1M | 100% |
| Filing → |
| REGN | SELL | 2022-10-03 | $10.2M | — | Filing → |
| DNLI | SELL | 2022-09-30 | $1.2M | — | Filing → |
| DNLI | SELL | 2022-08-25 | $632K | — | Filing → |